RxDoctor Payments Data

Caroline Avett

Physician Assistant · Marietta, GANPI 1598482432

Payments from drug & device makers

$2,981in general payments, 2019–2025

Across 123 payments — averaging $24.23 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • UCB, Inc.$595
  • Lilly USA, LLC$322
  • Novo Nordisk$261
  • Novartis$177
  • AbbVie$161
  • Astellas Pharma US Inc$145
  • plus $1K from 29 others

What the payments were for

  • Food & beverage$2,981100%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

What the payments were tied to

Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.

How this compares

$2,981 in reported general payments places this provider in the 80th percentile of 3,581 physician assistant providers in Georgia.

See all physician assistant providers in Georgia

Medicare billing

Part B allowed, 2024
$23,448
Medicare patients
128
Services billed
434

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
Atorvastatin Calcium37$290
Levothyroxine Sodium33$253
Fenofibrate11$247
Pantoprazole Sodium14$247
Metformin Hcl ErMetformin Hcl23$192
Gabapentin24$161
Omeprazole13$127
Trazodone Hcl17$120
Rosuvastatin Calcium16$120
Allopurinol11$110
Simvastatin17$99
Amlodipine Besylate27$92
Lisinopril17$80
Losartan Potassium15$77
Nitrofurantoin Mono-MacroNitrofurantoin Monohyd/M-Cryst18$75

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Amneal Pharmaceuticals LLCLevothyroxine Sodium$16$25333 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 3,581 physician assistant providers in Georgia.

Other physician assistant in Marietta

See the full list for Georgia

Where these figures come from

Is this you, or does something look wrong? →